|  | 
|  |  | 
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. | 
|   
 
    
    
    
All information on HEB and HEB warrants is up to date on the old thread, HEMX. HEB recently listed on the AMEX, having traded before on NASDAQ. Ampligen, its primary drug, is currently in phase III human clinical trials in the U.S.A. for treatment of CFS, chronic fatigue syndrome. This thread has been started for the benefit of those searching for the new symbol, HEB, and posts on either thread are welcome. | ||||||||||||||
| 
 
 | 
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings | 
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI | 
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |